GlaxoSmithKline Cash Flow Statement
View: Annual
| Dec 05 | Dec 04 | Dec 03 | |
|---|---|---|---|
| Net Operating Cash Flow | 9,896.3 | 8,897.0 | 8,705.8 |
| Net Investing Cash Flow | (3,171.4) | (1,903.5) | (1,607.8) |
| Net Financing Cash Flow | (4,145.4) | (5,853.0) | (5,426.2) |
| Net Change in Cash | 2,987.3 | 961.4 | 1,607.8 |
| Depreciation & Amortization | 1,555.6 | 1,716.6 | 1,529.5 |
| Capital Expenditures | (1,553.9) | (1,666.5) | (1,545.5) |
| Cash Dividends Paid | (4,260.7) | (4,768.3) | (4,149.2) |






